Company

Abbott Laboratories

Abbott Laboratories (NYSE: ABT) is a global medical device and healthcare company.

Founded: 1888
HQ: Abbott Park, IL
Status: duplicate (merged into abbott)

Overview

Abbott Laboratories (NYSE: ABT) is a global medical device and healthcare company. Developing robotic surgical systems, continuous glucose monitoring (Freestyle Libre), and AI-powered diagnostics. Makes strategic investments in medical robotics via Abbott Ventures.

Verified record

Verified deployments: None on file
Active incidents: None on file

Key facts

Focus

Medical devices, diagnostics, nutrition, and branded generics

Stage

Public company listed on NYSE under ticker ABT

Stocksee public companies →

NYSE: ABT

Products

Freestyle Libre CGM, robotic surgical systems, AI diagnostics

Data & sources

Web sources

1 source backing this record.View all →

Abbott Laboratories on the deployment map

View the global map

Abbott Laboratories has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

The global deployment map →

No verified deployments for Abbott Laboratories on the DEPLOY record yet. Track Abbott Laboratories to know the moment the first one is verified.

Current leadership (1)

Robert B. Ford Chairman & CEO

Safety record

No incidents on record for Abbott Laboratories.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Recent coverage

Abbott Laboratories in third-party press

Abbott Laboratories Lost 16% This Year: One Analyst Sees 35% Gains for the Healthcare Giant

Aug 3, 2026

4 Medical Products Stocks Poised to Win Despite Industry Headwinds - TradingView

Jul 20, 2026

World Intelligent Tissue Autonomous Robots - Market Analysis, Forecast, Size, Trends and Insights - IndexBox

Jul 19, 2026

Financial state

Reporting basis: aggregator_estimate
Lifecycle stage: early
Counterparty risk class: unknown

Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Record createdJun 8, 2026
Added to the verified registry

Full change history →

Sources (1)

https://www.abbott.com/

Common questions

What is Abbott Laboratories?

What does Abbott Laboratories make?

Abbott Laboratories has no robot models recorded on the DEPLOY registry. Abbott Laboratories builds both physical robots and the AI that runs them.

Is Abbott Laboratories publicly traded?

Yes. Abbott Laboratories is publicly traded on public markets, per the DEPLOY registry.

Who is the CEO of Abbott Laboratories?

Robert B. Ford is the ceo of Abbott Laboratories, per the DEPLOY registry.

How can I invest in Abbott Laboratories?

Abbott Laboratories is publicly traded (public markets), so its shares can be bought through any broker.

Where is Abbott Laboratories headquartered?

Abbott Laboratories is headquartered in Abbott Park, IL.

Who owns Abbott Laboratories?

Abbott Laboratories is publicly held by its shareholders.

Is Abbott Laboratories a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Abbott Laboratories ranks in roughly the top 9% of companies tracked by the registry.

When was Abbott Laboratories founded?

Abbott Laboratories was founded in 1888.

Is Abbott Laboratories safe?

Abbott Laboratories has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-21

Sources by quality tier

1: unclassified; Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Abbott Laboratories

Overview

Key facts

Data & sources

Abbott Laboratories on the deployment map

Current leadership (1)

Safety record

Recent coverage

Financial state

Recent activity

Sources (1)

Common questions

In the press

Abbott Laboratories Lost 16% This Year: One Analyst Sees 35% Gains for the Healthcare Giant

4 Medical Products Stocks Poised to Win Despite Industry Headwinds - TradingView

World Intelligent Tissue Autonomous Robots - Market Analysis, Forecast, Size, Trends and Insights - IndexBox

Hugging Face discloses an autonomous agentic breach. - N2K CyberWire

Bowden Cables Market Forecast Points Higher Toward 2035, Driven by Surgical Robotics Adoption - IndexBox

What Globus Medical (GMED)'s Robotics-Focused Institutional Interest Means For Shareholders - simplywall.st

3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List) - The Globe and Mail

China Robotics Firm Signs Star German Goaltender As Brand Ambassador - Forbes

ISRG's SP Platform: Early-Stage Growth or Next TAM Expansion Driver? - TradingView

Robotic Catheter Navigation System Market Size | CAGR of 11.0% - Market.us

Tired of AI and Oil? Buy the Robot. - Trefis

Abbott Completes $21B Exact Sciences Deal To Expand Cancer Diagnostics - insights.citeline.com

Machine-readable surfaces